Rocket Doctor has entered into a reseller agreement with Remmie, Inc., maker of the Remmie 4, an FDA approved and Health Canada Medical Devices Establishment Licence (MDEL) cleared USB-smart otoscope for at-home ear exams.
Rocket Doctor AI Inc. announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has entered into a reseller agreement with Remmie, Inc., the Seattle-based medical device company behind the Remmie 4, an FDA and Health Canada MDEL cleared USB-smart otoscope designed for easy, at-home ear exams.
Health Technology Insights: Lirio Appoints Inaugural Advisory Board to Drive the Company’s Next Phase of Growth
The Remmie 4 integrates with the Remmie App and AI solution Remmie.ai, enabling patients to digitally photograph and capture videos of their ear, mouth, and nose. These high-quality visuals can then easily be shared directly with physicians on the Rocket Doctor platform, allowing clinicians to conduct faster, more accurate telehealth assessments and pre-visit exams. By empowering patients to perform these exams from the comfort of home, the partnership helps improve efficiency, reduce unnecessary clinic visits, and provide timely care for common conditions like ear infections.
A Memorandum of Understanding (MOU) was entered into on12th September 2025. This MOU outlines the intent of the parties in respect of Rocket Doctor reselling Remmie’s devices. Either party may propose amendments or terminate this MOU upon written notice.
Health Technology Insights: Freed Unveils EHR Push: One-Click AI Note Transfer Into Any Web-Based EHR
Through this agreement, Rocket Doctor will initially distribute Remmie 4 devices across Canada, with each device co-branded through Rocket Doctor packaging. Patients purchasing through Rocket Doctor will receive a 20% discount using unique discount codes, making this advanced diagnostic tool more accessible to families nationwide. We will have further updates on the availability of this program to our U.S. patients.
“Our mission at Remmie has always been to make ear health simple, accessible, and effective,” said Jane Zhang, Founder & CEO of Remmie, Inc. “By partnering with Rocket Doctor, we’re bringing the Remmie 4 to more families in Canada, giving them the tools to take charge of their care and connect more seamlessly with clinicians.”
Together, Remmie and Rocket Doctor are enabling a new model of care where patients can combine at-home diagnostic tools with physician-led virtual visits, ensuring more accurate assessments, faster treatment, and greater convenience. The collaboration underscores how connected devices and virtual care platforms can work hand-in-hand to address everyday health issues while reducing strain on traditional healthcare systems.
“Rocket Doctor is committed to transforming healthcare delivery by connecting patients with technology that makes care more accessible and efficient,” said Dr. William Cherniak, CEO of Rocket Doctor Inc. “Partnering with Remmie allows us to expand our connected device ecosystem, giving our patients new ways to participate in their own care while strengthening the diagnostic confidence of virtual visits requiring an ear exam with our clinicians.”
With over 300 MDs empowered to care for over 700,000+ patients across Canada, Rocket Doctor has already established itself as one of the country’s leading digital health companies.
Looking ahead, U.S. expansion discussions for the Remmie program are underway. By integrating connected diagnostic tools like the Remmie 4 into its U.S. operations, Rocket Doctor aims to reduce travel burdens, shorten wait times, and deliver higher-quality care directly into patients’ homes.
This collaboration with Remmie further strengthens Rocket Doctor’s ability to deliver accessible, technology-driven solutions that empower patients and support clinicians, while advancing its mission to expand access to care for rural and remote populations, and underserved communities across North America.
Health Technology Insights: GSK and IQVIA Launch Local Vaccine Data for Public Health
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobeNewswire
